Corcept Therapeutics
CORT
#3229
Rank
NZ$8.34 B
Marketcap
NZ$78.44
Share price
5.00%
Change (1 day)
-25.18%
Change (1 year)

Earnings for Corcept Therapeutics (CORT)

Earnings in 2025 (TTM): NZ$75.18 Million

According to Corcept Therapeutics 's latest financial reports the company's current earnings are NZ$0.76 Billion. a decrease over its 2024 earnings that were of NZ$0.23 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Corcept Therapeutics from 2003 to 2025

Annual earnings

Year Earnings Change
2025 NZ$76.11 M-67.29%
2024 NZ$0.23 B27.66%
2023 NZ$0.18 B-4.75%
2022 NZ$0.19 B-9.51%
2021 NZ$0.21 B-2.91%
2020 NZ$0.21 B14.87%
2019 NZ$0.18 B24.71%
2018 NZ$0.15 B69.32%
2017 NZ$89.81 M419.26%
2016 NZ$17.29 M-395.64%
2015 -NZ$5.86 Million-87.53%
2014 -NZ$46.94 Million-33.44%
2013 -NZ$70.52 Million
2011 -NZ$54.94 Million17.84%
2010 -NZ$46.63 Million35.5%
2009 -NZ$34.41 Million2.84%
2008 -NZ$33.46 Million60.81%
2007 -NZ$20.81 Million-52.14%
2006 -NZ$43.48 Million20.91%
2005 -NZ$35.96 Million31.87%
2004 -NZ$27.27 Million60.54%
2003 -NZ$16.99 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$57.01 B 74,797.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$27.78 B 36,402.44%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$17.31 B 22,651.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$43.72 B 57,339.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$38.10 B 49,954.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$15.85 B 20,722.82%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
NZ$52.3 M-31.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
-NZ$46.63 Million-161.26%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
NZ$0.81 B 977.04%๐Ÿ‡บ๐Ÿ‡ธ USA